Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells. 2007

Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
Department of Ophthalmology, College of Medicine, National Cheng Kung University, Taiwan.

OBJECTIVE To investigate the toxic effects of triamcinolone acetonide (TA) suspensions on human retinal pigment epithelial (RPE) cells. METHODS Cultured human RPE cells were exposed for up to 2 hours to one of seven solutions: control (balanced salt solution, BSS; Alcon Laboratories, Ft. Worth TX), commercial TA suspension (cTA), cTA from which the vehicle (which contains the preservative benzyl alcohol) had been removed (vehicle-removed TA, -vTA), vehicle of the cTA (V), or a 1:10 dilution (in BSS; Alcon) of cTA, -vTA or V. Solution effects were evaluated by phase-contrast microscopy of cells stained in situ with trypan blue and in vitro by trypan blue exclusion assay. RPE cell function was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The mechanism of TA toxicity was studied by acridine orange-ethidium bromide staining and epifluorescence microscopy, and ultrastructural changes were examined by transmission electron microscopy (TEM). RESULTS The effects of vehicle-removed solutions (-vTA and 1:10 -vTA) were similar to those of the control solution. Exposure for 1 hour or longer to a vehicle-containing solution (cTA and V) resulted in similar and significant degrees of cell damage that were dose and time dependent. The major mechanism of cell death was necrosis, and the early ultrastructural change was swelling of organelles in the cytoplasm. CONCLUSIONS Preserved commercial TA suspensions damaged human RPE cells, but vehicle-free solutions did not. The authors suggest removing the vehicle as completely as possible from TA solutions before they are administered intravitreally. Furthermore, they recommend that a commercial formulation of preservative-free TA suspension be made available for intraocular use.

UI MeSH Term Description Entries
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D008858 Microscopy, Phase-Contrast A form of interference microscopy in which variations of the refracting index in the object are converted into variations of intensity in the image. This is achieved by the action of a phase plate. Phase-Contrast Microscopy,Microscopies, Phase-Contrast,Microscopy, Phase Contrast,Phase Contrast Microscopy,Phase-Contrast Microscopies
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D010857 Pigment Epithelium of Eye The layer of pigment-containing epithelial cells in the RETINA; the CILIARY BODY; and the IRIS in the eye. Eye Pigment Epithelium
D011310 Preservatives, Pharmaceutical Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants. Pharmaceutic Aids (Preservatives),Pharmaceutic Preservative,Pharmaceutic Preservatives,Pharmaceutical Preservative,Pharmaceutical Preservatives,Preservative, Pharmaceutic,Preservative, Pharmaceutical,Preservatives, Pharmaceutic
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004396 Coloring Agents Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. Coloring Agent,Dye,Dyes,Organic Pigment,Stain,Stains,Tissue Stain,Tissue Stains,Organic Pigments,Pigments, Inorganic,Agent, Coloring,Inorganic Pigments,Pigment, Organic,Pigments, Organic,Stain, Tissue,Stains, Tissue
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic

Related Publications

Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
February 2006, Investigative ophthalmology & visual science,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
August 2009, Medical science monitor : international medical journal of experimental and clinical research,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
September 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
January 2004, Japanese journal of ophthalmology,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
January 2011, Chang Gung medical journal,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
May 2009, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
November 2007, Acta ophthalmologica Scandinavica,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
August 2007, Acta ophthalmologica Scandinavica,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
January 2012, International journal of nanomedicine,
Yi-Sheng Chang, and Chao-Liang Wu, and Sung-Huei Tseng, and Pao-Ying Kuo, and Shih-Ya Tseng
January 2007, The British journal of ophthalmology,
Copied contents to your clipboard!